High Throughput Screening: Enables Automated Assays of Biological or Biochemical Activity of Compounds Similar to Drugs

High Throughput Screening (HTS) refers to a scientific experimentation method used in the process of drug discovery. HTS enables automated assays of biological or biochemical activity of compounds similar to drugs. These assays facilitate discovery of enzymes, ligands for receptors and other pharmacological tests. In addition this process aids in rapid identification of antibodies, genes or active compounds that are responsible for alteration of a specific biomolecular pathway. Presently, the HTS industry is expected to reduce the costs involved in drug discovery process and release the potential lead compounds resultant from screening campaigns. This expectation led HTS industry to adopt smarter screening procedures by screening only focused and potential compounds along with the use of highly efficient instrumentation platforms. 

The HTS industry poses a competitive environment, with regular technology transfers and information sharing between the market rivals. With the increasing competition between the pharma companies to pioneer the drug commercialization, the need for HTS increases simultaneously, as this reduces the overall time required for commercializing the drug molecules. HTS market promises affirmative growth potential in near future due to its inevitable use in the research and production fields and can be segmented by technology, applications and geography. Some of the technological advances in the HTS industry attribute to introduction of high content screening technologies, miniaturization of the HTS technological platforms and novel cell culture approaches. 

The major factors positively impacting the growth of the market accounts for continuous HTS technological upgradations, rigorous research and development initiatives, increase in investments by the drug discovery firms and focus on development of robust hardware and software used in screening. On the other hand increasing demand for highly efficient biochemical assays, need for cost effective solutions and negative impacts of economic slowdown on HTS outsourcing might hamper the growth of HTS market. Some of the major players competing in this market are Agilent Technologies, Inc., Aurora Biomed, Inc., Sigma-Aldrich Corporation, Life Technologies Corporation, Luminex Corporation, Beckman Coulter, Inc., and Roche Applied Sciences.

Medical Textiles: People are now Practicing Different Methods of Hygiene, using Antiseptics for Wound Control

Healthcare textiles are known as medical textiles. It is one of the rapidly growing sectors in the technical textile market. Textile materials for healthcare and medical products ranges from simple bandage materials or gauze to scaffolds for tissue repairing and a large variety of prostheses for body implants. Usage   of medical textiles depends on their properties like flexibility, absorption, softness, filtering among others. Medical textiles can be classified as implantable materials, non-implantable materials, healthcare and hygiene products and extracorporeal products. Medical textiles find applications in medical and biological sectors. They are used for first aid, rehabilitation, hygienic purposes, or clinical purpose. Medical textiles are used for wound care, protecting the wound form infection, bandaging & pressure garment. Furthermore it is used for extra corporal and implantable material like art.

The burgeoning population is expected to be one of the primary drivers for the medical textile market. Furthermore, change in the standard of living and demographics are also expected to enhance the market growth. People are now practicing different methods of hygiene, using antiseptics for wound control among others Some of the restraining factors affecting the industry are high cost, lack of availability of raw materials, unawareness/ignorance of hygiene among people of developing nations.

Obtain the Future Market Trends of Medical Textiles: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1701

Europe is one of the leading markets in the medical textile industry. U.K, France, Italy and Germany hold the larger segment of the market. North America follows Europe, while Asia Pacific is one of the emergent markets. Countries are now supporting and providing various schemes in order to promote the production and consumption of medical textile. One such scheme offered by the Govt. of India is the Technology Mission on Technical Textiles where the Govt. will be investing 200crs in this particular industry.

Principal manufacturers in the medical textile industry are Kimberly-clark Corporation, Beiersdorf India Pvt. Ltd, Johnson & Johnson, Honeywell International, Imedex Biomateriaux, among others.

Home Infusion Therapy - Administration of Medications through Needles and Catheters

Infusion therapy refers to the administration of medications through needles and catheters. These procedures are usually performed when oral medication treatments are not effective on the patients. Home infusion therapies are those infusion therapies that can be taken by the patient at home, upon prescription by a physician. Home infusion therapies are taken either through intravenous (IV) routes into the bloodstream or a tube placed in the patient’s intestine or stomach.

Various drug therapies are performed at home including pain management, parenteral nutrition, antibiotics and IVIG therapy. In addition, insulin home infusion therapy is also performed; it is the most widely used home infusion therapy. Pain killers and IVIG account for the major market shares after insulin. IVIG can be allowed to be administered to a patient after the diagnosis of congestive heart failure, neurological disorders and immune disorders. Home infusion therapy requires administrative services, pharmacy services, patient educating and training, equipments, care coordination and supplies.

Change in lifestyle will boost the growth of home infusion therapy market. In addition, increase in diabetic population and reduction in treatment cost will also trigger the growth of this market. Many complicated medical conditions and illnesses can be treated with these infusion therapies which will reduce the hospital stay, and hence reduce the cost of treatment as well. Home infusion therapies are safer since the administration of the drugs is observed by physicians. This will also augment the growth of this market. Reimbursement policies of various public and private firms will also boost the growth of this market.

Forthcoming Projections for the Market of Home Infusion Therapy: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1702

Despite all these, sometimes overdosage of medications may cause hazardous conditions which may hinder the growth of this market. The major players operating in this market include Abbott Laboratories, Stryker Corporation, Continuum Rx, Bristol-Myers Squibb, and Eli Lilly and Company, among other significant players.

HPLC - A Versatile Technique for Analyzing All types of Biological Compounds that can be Isolated or Synthesized

High-Performance Liquid Chromatography (HPLC), a chromatographic technique is used to identify, quantify and separate each component from a sample of complex chemical mixtures. Presently, HPLC is a versatile technique, available for analyzing all types of biological compounds that can be isolated or synthesized. This method involves the passage of liquid sample over solid adsorbent material packed in a column with solvent. HPLC technique has been used in various fields such as legal, medical, manufacturing processes and in research. This technique relies on pumps and other accessories to pass the sample through the column filled with sorbent (active ingredient of the column). HPLC is highly efficient and different from the conventional liquid chromatographic methods in terms of high operational pressures used in HPLC to run the mobile phase through the column. In addition, the resolution power of HPLC used during separation is higher when compared to conventional liquid chromatographic techniques. The market for HPLC systems and accessories holds immense growth potential due to extensive use of this technique in wider application areas such as pharmaceuticals, food and beverage industry, industrial chemicals sector, etc. and its effectiveness and accuracy over the traditional processes. 

HPLC systems and accessories include products and components involved in the identification, analysis and separation process. Market for HPLC systems and accessories can be segmented by product type, applications and geography.  The various products include sample injectors, pumps, columns, fraction collectors, detectors and others.  The HPLC technique has applications in various fields such as life sciences research, industrial chemicals, manufacturing processes, etc.

Get the Upcoming Market Projections for HPLC Systems & Accessories: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1703

The major factors augmenting growth of the market are rigorous investments by both established and start up firms, emergence of robotics and updated automation systems, rapid advancements in pharmaceutical and biotechnological research. In addition, with the introduction of economic devices and integrated technological platforms are expected to play an instrumental role in enhancing the use and uptake of HPLC systems and accessories. Threat of substitutes and emergence of local players results into perfect competition markets, might hamper the growth of the market. Some of the major players in the market are Agilent Technologies, Inc., Thermo Fisher Scientific Inc., Shimadzu Corp., Sigma-Aldrich Corporation and Hichrom Limited.

Pediatric drugs - Special Drugs which are Prescribed to Children and Infants for Different Diseases

Pediatric drugs are a special class of drugs which are prescribed to children and infants for different diseases.  These drugs are recommended in various conditions such as asthma, anorexia, birth defects, cancer in children, growth deficiencies, juvenile diabetes, attention deficit hyperactivity disorder, and others. Various acts have been passed to control pediatric drugs such as Best Pharmaceuticals for Children Act (BPCA) and the Pediatric Research Equity Act (PREA). These acts have been introduced to increase the investments on R&D for pediatric drugs and to increase the drugs count prescribed for children and infants.

Pediatric drugs are categorized in three segments namely pediatric clinical pharmacology, pediatric pharmacotherapy and pediatric pharmacy. Pediatric pharmacotherapy focuses on those drugs which will behave differently in children and adults. Pediatric clinical pharmacology includes those drugs which are helpful for mental and physical growth. Pediatric pharmacy includes all those drugs which are specifically meant for children. To treat various disease conditions different drugs are prescribed such as acetaminophen, fentanyl, ibuprofen, naloxone and methadone are given as analgesics. In addition, cefazolin, ampicillin and meropenem are prescribed to treat microbial infections whereas clonidine and etomidate are recommended for sedative effect. Various other drugs are tramadole, oxycodone, codeine, lorazepam and gabapentin.

Growing concerns globally, amongst parents has assisted the growth of this segment. Moreover, governments worldwide are funding and initiating various national programs to support use of drugs to curb infant and child mortality rates. Rise in disposable income along with awareness in people has augmented the growth of pediatric drugs in developed nations such as U.S. and Europe. In addition, rising incidence of disease conditions such as obesity, diabetes and hypertension in children have also contributed in its growth. Despite various developments, low disposable income and unawareness in developing nations are hindering the growth of this market. Moreover, side effects such as anxiety, headache and fatigue are also restricting its growth.

Some of the major market players of pediatric drug include InfaCare Inc., Medeira Therapeutics, Crucell Biologics Inc., Actelion Pharma ceuticals Ltd. and other significant players.

Health Care Social Media Marketing: Social Media Platform is No More an Option Today, It's a Necessity

Social media marketing is an upcoming field; the emergence of which has been fueled by the rapid rise of social media in recent years. Over the last decade, social media such as Facebook, Twitter, LinkedIn, and others have gone from being a novelty to an everyday necessity. Due to the ease of sharing information with the masses, social media marketing has caught on in the last few years.

Health care is the latest sector to join the social media marketing bandwagon. The ease of sharing information on social media has led many medical equipment manufacturers and other entities in the health care field to advertise their products and services on social media and interact with the customers about the same.

The increasing number of social media users is responsible for the rising demand from the health care social media marketing market. The high proportion of the global population with access to high-speed internet and the requisite amount of tech literacy has led to high demand for the availability of medical knowledge on the internet, thus spurring the global health care social media marketing market.

However, the market is held back by restraints such as the possibility of fraudulent information being passed as genuine and the concern for privacy. The lack of privacy in social media is a well-debated topic already, lending weight to the reluctance of some users to post sensitive medical information on the internet.

Perceive the Future Market Projections for Health Care Social Media Marketing at:

http://bit.ly/2fU0gjf

Apart from advertising, social media marketing is also a powerful tool for interacting with potential customers. Customer feedback about upcoming products and procedures can even be directly implemented in health care products, making them more in line with what the customer actually needs and wants.

 Regionally, North America emerged as the leading market for health care social media marketing in 2014. The high number of tech-savvy customers and rising usage of and government support for telehealth systems are the main factors driving the North America health care social media marketing market. In the coming years, the Asia Pacific and Rest of the World market for health care social media marketing are expected to emerge as strong contenders in the global scenario, due to the rising availability of high-speed internet and growing social media user base in developing countries such as China, India, Indonesia, South Korea, Brazil, Argentina, and Chile.

Ingestible Sensors: Consume Technology and Receive Medical Benefits

Ingestible sensors is an innovative technologically advanced product of digital medical industry. Ingestible Sensors are pills that have the ability to detect various bodily functions and activities, medication check, heart rate and blood pressure. It has three components sensors, data recorder, and software. These ingestible sensors help patients receive real-time information and address the unaware issues which are sometimes not answered by doctors. The ingestible sensor works as soon as the sensor enabled pill is consumed. This pill sends signals to the patch, which helps to detect the duration in which the pill was consumed. As the data is recorded, the information is being displayed with the help of linked discover application that can be downloaded on a mobile device. With the help of this application patients can analyze the data and work accordingly, this helps them to decide if there is any need to visit a healthcare provider, taking medication on time and others. The ingestible sensors market is driven by increasing prevalence of chronic conditions and advancement in technology.

The Centers for Disease and Control of Infection states that about 36.5% of the overall adults in the U.S. suffer from obesity and related conditions. Obesity has led to a high prevalence of heart disease, diabetes, certain types of cancer, and stroke amongst other diseases. This reason alone has provided the overall ingestible sensors market in a terrific momentum with North America in the lead. These sensors gather real-time information and offer an effective solution for the issues that most patients or doctors cannot identify. Today, these sensors are linked to the smartphones and thus help the patients to analyze the data and improve disease management.

Analysts predict that changing lifestyles that tilting towards sedentary patterns and the growing number chronic condition cases are anticipated play a crucial role in the growth of the global ingestible sensors market. The rising disposable incomes, improving healthcare infrastructure in developing countries, and growing awareness about options for treating a disease are all expected to a significant contribution to the global ingestible sensors market in the coming few years. The report indicates that Asia Pacific will also emerge as a leading segment as the region boasts a significant pool of geriatrics and exhibits a large number of unmet medical needs. Furthermore, the entry of new players will also offer end users such as research institutes, healthcare providers, pharmaceutical companies, and sports and physical fitness institutions myriad options at competitive pricing.

Obtain the Futuristic Insights for Ingestible Sensors at: http://bit.ly/2gnNElj

North America followed by Europe is dominating the Ingestible sensors market as a high incidence of gastroparesis cases, and favorable reimbursement options provided by governments and insurance companies which have provided the platform for these products. In Asia Pacific region the Ingestible sensors market is expected to deliver significant growth due to the high pool of geriatric population in this region and growing economy which is expected to further fuel market demand. Moreover, the Ingestible sensors market is expected to become highly competitive due to the potential entrants in the market by the end of forecast period.

Some of the leading players operating in the global ingestible sensors market are CapsoVision, Inc., HQ, Inc., Given Imaging, Ltd., Proteus Digital Health, Inc., Olympus Corporation, and Medimetrics Personalized Drug Delivery B.V. The research report provides a complete analysis of the competitive landscape present in the global market. Furthermore, it also offers an assessment of the research and development activities of these companies, their business and marketing strategies, and expansion plans for the coming few years. Additionally, the document also provides a compilation of comments and recommendations from expert market players for the existing and new players to help them formulate their strategies.